Last update :
03/05/2024
References   References 4279  
Type : Journal
Web link : https://doi.org/10.1007/s40259-019-00342-9

Research teams : Grenade - Faculty of Science, Department of Analytical Chemistry
Authors : Hermosilla J, Sanchez-Martin R, Pérez-Robles R, Salmeron-Garcia A, Casares S, Cabeza J, Cuadros-Rodriguez L, Navas N.
Title : Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA).
Reference : Bio Drugs ; 33: 193–205. 2019

Level of Evidence : 
Level of evidence A+
Physical stability : 
Protein: Size Exclusion Chromatography Protein: Dynamic Light Scattering 
Chemical stability : 
Other methods : 
Comments : 
Proteins: biological activity by cell culture

List of drugs
InjectionInfliximab Immunosuppressant
Stability in solutions Glass Water for Injection 10 mg/ml 2-8°C Not specified
14 Day
Stability in solutions Glass Water for Injection 10 mg/ml 2-8°C Not specified
14 Day
Biosimilar
Stability in solutions Polyolefine Sodium chloride 0,9% 0,4 mg/ml 2-8°C Not specified
14 Day
Biosimilar
Stability in solutions Polyolefine Sodium chloride 0,9% 0,4 mg/ml 2-8°C Not specified
14 Day
Stability in solutions Polyolefine Sodium chloride 0,9% 2 mg/ml 2-8°C Not specified
14 Day
Stability in solutions Polyolefine Sodium chloride 0,9% 2 mg/ml 2-8°C Not specified
14 Day
Biosimilar

  Mentions Légales